COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.

Edoardo ConticiniElena BargagliMarco BardelliGiuseppe Domenico RanaCaterina BaldiPaolo CameliStefano GentileschiDavid BennettPaolo FalsettiNicola LanzaroneFrancesca BellisaiCristiana BarrecaRoberto D'AlessandroLuca CantariniBruno Frediani

Published in: Annals of the rheumatic diseases (2020)

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
cancer therapy
rheumatoid arthritis patients
respiratory syndrome coronavirus
respiratory failure
community acquired pneumonia
drug induced
drug delivery
intensive care unit
systemic lupus erythematosus